Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ines Colmegna

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Vaccines|February 26, 2025
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) StudyJeremiah Tan, Sasha Bernatsky, Jennifer L F Lee, et al.
Bioinformatics (Oxford, England)|October 27, 2015
funtooNorm: an R package for normalization of DNA methylation data when there are multiple cell or tissue typesKathleen Oros Klein, Stepan Grinek, Sasha Bernatsky, et al.
The Journal of Rheumatology|May 16, 2021
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic DiseasesGlen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, et al.
Vaccines|September 28, 2024
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED StudyOlga Tsyruk, Gilaad G Kaplan, Paul R Fortin, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic DiseasesCarrie Ye, Roko P A Nikolic, May Choi, et al.
Microscopy Research and Technique|November 9, 2005
Involvement of human intracisternal A-type retroviral particles in autoimmunityDavid M Sander, Sara Szabo, William R Gallaher, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory ArthritidesCarrie Ye, Roko P A Nikolic, May Choi, et al.
AIDS and Behavior|February 4, 2023
Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian SurveyCecilia T Costiniuk, Joel Singer, Judy Needham, et al.
Vaccine: X|November 25, 2024
Sex differences in COVID-19 vaccine confidence in people living with HIV in CanadaJessica Lu, Branka Vulesevic, Ann N Burchell, et al.
The Journal of Rheumatology|April 15, 2024
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) StudyDawn M E Bowdish, Vinod Chandran, Carol A Hitchon, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Vaccines|February 26, 2025
COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) StudyJeremiah Tan, Sasha Bernatsky, Jennifer L F Lee, et al.
Bioinformatics (Oxford, England)|October 27, 2015
funtooNorm: an R package for normalization of DNA methylation data when there are multiple cell or tissue typesKathleen Oros Klein, Stepan Grinek, Sasha Bernatsky, et al.
The Journal of Rheumatology|May 16, 2021
Canadian Rheumatology Association Recommendation for the Use of COVID-19 Vaccination for Patients With Autoimmune Rheumatic DiseasesGlen S Hazlewood, Jordi Pardo Pardo, Cheryl Barnabe, et al.
Vaccines|September 28, 2024
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED StudyOlga Tsyruk, Gilaad G Kaplan, Paul R Fortin, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic DiseasesCarrie Ye, Roko P A Nikolic, May Choi, et al.
Microscopy Research and Technique|November 9, 2005
Involvement of human intracisternal A-type retroviral particles in autoimmunityDavid M Sander, Sara Szabo, William R Gallaher, et al.
The Journal of Rheumatology|September 15, 2025
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory ArthritidesCarrie Ye, Roko P A Nikolic, May Choi, et al.
AIDS and Behavior|February 4, 2023
Understanding COVID-19 Vaccine Confidence in People Living with HIV: A pan-Canadian SurveyCecilia T Costiniuk, Joel Singer, Judy Needham, et al.
Vaccine: X|November 25, 2024
Sex differences in COVID-19 vaccine confidence in people living with HIV in CanadaJessica Lu, Branka Vulesevic, Ann N Burchell, et al.
The Journal of Rheumatology|April 15, 2024
When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) StudyDawn M E Bowdish, Vinod Chandran, Carol A Hitchon, et al.
Pageof 5